3-(2-Fluorophenyl)-1,1,1-trifluoro-2-propanone, 97.0%, 2g

1,4-Dichlorobutane-2,3-diol, 97%, 1g

(S)-4-(6-(3,5-Dimethylisoxazol-4-yl)-1-(1-(pyridin-2-yl)ethyl)-1H-pyrrolo[3,2-b]pyridin-3-yl)benzoic acid, 98.00%, 100mg

3-(1,3-Dioxo-1,3-dihydroisoindol-2-yl)-propionaldehyde, 95.0%, 1g

2,2-Dimethyl-2H-pyrido[3,2-b][1,4]oxazin-3(4H)-one, 95.0%, 10g

Narrow mouth bottle 301, 500 ml, 25 mm, 10 Piece(s)

(2S,3S)-2-BENZYL-3-(TERT-BUTYL)-4-(2,6-DIMETHOXYPHENYL)-2,3-DIHYDROBENZO[D][1,3]OXAPHOSPHOLE, 95%, 500mg

Glass tubes, 6 mm, 12 Piece(s)

(3-(Benzylcarbamoyl)-5-fluorophenyl)boronic acid, 95.0%, 5g

(2R,4R)-4-Methylpiperidine-2-carboxylic acid, 97.0%, 250mg

N,N'-(ETHANE-1,2-DIYL)DIACRYLAMIDE, 97.0%, 25g

1-(Diphenylmethyl)-3-hydroxyazetidine hydrochloride, 95.0%, 5g

3-Bromo-1-ethanesulfanylbenzene, 98%, 5g